Skip to main content

Free Content Antiparasitical chemotherapy in Chagas’ disease cardiomyopathy: current evidence

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library


Chronic chagasic cardiomyopathy affects 20% of Chagas’ disease patients. At present, Chagas’ disease chemotherapy uses nitrofurans, benznidazole (Rochagan®, Rodanil®, Roche) or nifurtimox (Lampit®, Bayer). Treatment during acute and recent chronic phases in childhood effects 71.5% and 57.6%, respectively, of parasitological cure. However, in clinical trials during the late chronic phase, only 5.9% of parasitological cure were achieved. This review focuses on the benefit from aetiological treatment to avoid, stop or revert myocarditis. Divergent data gathered from clinical practice are not convincing to support prescription of aetiological treatment as routine for indeterminate and cardiac chronic patients.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Language: English

Document Type: Research Article

Affiliations: 1:  Department of Microbiology and Parasitology, Bioscience Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil 2:  School of Medicine, University Antonio Nariño, Bogotá, Colombia 3:  Department of Biochemistry and Immunology, Medicine School at Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil 4:  Laboratory of Cellular Ultrastructure, Oswaldo Cruz Institute-FIOCRUZ, Rio De Janeiro, Rio de Janeiro State, Brazil

Publication date: 2012-09-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more